VIE/HSIC (VIE/HSIC)

Vienna Stock Exchange: VIE/HSIC · EUR

€77.0

+0.50 (+0.7%)· Recorded snapshot

Market cap	8.6B
Revenue (ttm)	11.9B
Net income (ttm)	353.4M
EPS (ttm)	€3.07
P/E (trailing)	25.1x
P/E (forward)	14.9x

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 11.9B
Net income (ttm): 353.4M
EPS (ttm): €3.07
P/E (trailing): 25.1x
P/E (forward): 14.9x
Market cap: 8.6B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 19:55 UTC

Forward P/E14.9

P25 n/aP50 n/aP75 n/a

Trailing P/E25.1

P25 n/aP50 n/aP75 n/a

ROE8.9

P25 n/aP50 n/aP75 n/a

ROIC7.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All VIE/HSIC indicators

Market & fundamental data

Available fields

233

Groups with data

Currency

USD

Showing 233 of 233 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	AT
Earnings date	2026-11-03
Employees	25,000
Employees change	0
Employees growth	0%
Enterprise value	EUR 13.3B
Exchange	Vienna Stock Exchange
Financial currency	USD
Financial report date	2026-06-27
First seen	2026-05-10
Fiscal year end	December
Founded	1932
Industry	Medical Distribution
Is primary listing	No
ISIN number	US8064071025
Last earnings date	2026-08-04
Last refreshed	2026-10-30
Last stock split date	2017-09-15
Last stock split type	Forward
Market cap	EUR 8.6B
Next earnings date	2026-11-03
Price	EUR 77.00
Price currency	EUR
Sector	Healthcare
SIC code	5047
Stock price date	2026-10-29
Symbol	vie/HSIC
Website	https://www.henryschein.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	21.52x
Average P/E ratio (3Y)	23.14x
Average P/E ratio (5Y)	21.33x
Earnings yield	3.98%
EV/Earnings	37.66x
EV/EBIT	18.88x
EV/EBITDA	12.47x
EV/FCF	26.67x
EV/Sales	1.09x
FCF / EV yield	3.75%
FCF yield	5.78%
Forward P/E	14.89x
Graham number	51.20355
Graham upside	-33.5%
Lynch fair value	EUR 15.77
Lynch upside	-79.52%
P/(FCF - SBC) ratio	18.57x
P/(OCF - SBC) ratio	14.89x
P/B ratio	2.08x
P/E ratio	25.11x
P/FCF ratio	17.3x
P/OCF ratio	14.06x
P/S ratio	0.72x
Price/EBITDA ratio	9.11x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	5.76%
EBITDA margin	7.94%
Effective tax rate	23.66%
FCF margin	4.1%
Gross margin	31.32%
Operating margin	5.76%
Pretax margin	4.1%
Profit margin	2.96%
Profit per employee	EUR 14,134
Profitable quarters	24
Profitable years	28
Revenue per employee	EUR 477,049
ROA	4.39%
ROA (5Y)	5.34%
ROCE	9.92%
ROE	8.85%
ROE (5Y)	10.47%
ROIC	7.11%
ROIC (5Y)	9.38%
SBC / revenue	0.29%
Tax / revenue	0.97%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	10.33%
EPS growth (Q)	17.14%
EPS growth (QoQ)	-10.87%
EPS growth 10Y	1.52%
EPS growth 3Y	0.28%
EPS growth 5Y	-4.09%
EPS growth quarters	4
EPS growth years	1
FCF growth	50.13%
FCF growth (Q)	140.91%
FCF growth 3Y	2.27%
FCF growth 5Y	-6.18%
Gross profit growth	6.45%
Gross profit growth (Q)	8.37%
Gross profit growth 3Y	3.39%
Gross profit growth 5Y	4.64%
Net income growth	3.6%
Net income growth (Q)	9.3%
Net income growth (QoQ)	-12.15%
Net income growth 3Y	-4.17%
Net income growth 5Y	-7.84%
Net income growth quarters	1
Net income growth years	1
OCF growth	36.72%
OCF growth (Q)	101.67%
OCF growth 10Y	1.47%
OCF growth 3Y	2.34%
OCF growth 5Y	-3.42%
Operating income growth	6.82%
Operating income growth (Q)	13.71%
Operating income growth 3Y	-2.74%
Operating income growth 5Y	-1%
Revenue growth	6.49%
Revenue growth (Q)	6.73%
Revenue growth (QoQ)	2.67%
Revenue growth 10Y	2.03%
Revenue growth 3Y	2.59%
Revenue growth 5Y	2.71%
Revenue growth quarters	5
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -114.9M
Depreciation and amortization	EUR 265.4M
EBIT	EUR 686.5M
EBITDA	EUR 946.9M
EPS	EUR 3.07
Financing cash flow	EUR -334.1M
Free cash flow	EUR 498.9M
Free cash flow minus SBC	EUR 464.7M
Gross profit	EUR 3.7B
Income taxes	EUR 115.7M
Investing cash flow	EUR -290.2M
Net borrowing	EUR 390.5M
Net cash flow	EUR 10.5M
Net income	EUR 353.4M
Operating cash flow minus SBC	EUR 579.6M
Operating income	EUR 686.5M
Revenue	EUR 11.9B
Stock-based compensation	EUR 34.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.71
Book value per share	EUR 24.73
Debt / EBITDA	3.21
Debt / equity	0.81
Debt / FCF	6.7
Goodwill	EUR 3.8B
Interest coverage	4.92
Long-term assets	EUR 5.9B
Long-term liabilities	EUR 2.7B
Net cash (debt)	EUR -3.2B
Net cash / market cap	-37.15%
Net debt / EBITDA	3.39
Net debt / equity	0.77
Net debt / FCF	6.43
Piotroski F-Score	5
Property, plant and equipment	EUR 840.1M
Shareholders' equity	EUR 4.1B
Tangible book value	EUR -1.8B
Tangible book value per share	EUR -16.30
Total assets	EUR 10B
Total cash	EUR 137.7M
Total debt	EUR 3.3B
Total liabilities	EUR 5.8B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.22
Current assets	EUR 4.1B
Current liabilities	EUR 3.1B
Current ratio	1.32
Inventory turnover	4.71
Net working capital	EUR 1.9B
Quick ratio	0.55
Working capital	EUR 975M
Working capital turnover	10.16

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	6.06%
Shareholder yield	6.06%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 71.79
1D price change	0.65%
1M price change	1.99%
1M total return	1.99%
1W price change	1.99%
1W total return	1.99%
1Y price change	40.92%
1Y return CAGR	40.96%
1Y total return	40.92%
20-day SMA	EUR 75.85
200-day SMA	EUR 70.36
3M price change	2.67%
3M total return	2.67%
3Y price change	23.04%
3Y return CAGR	7.16%
3Y total return	23.04%
50-day SMA	EUR 76.19
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 80.00
52-week high date	2026-09-03
52-week low	EUR 53.62
52-week low date	2025-10-30
5Y price change	18.57%
5Y return CAGR	3.47%
5Y total return	18.57%
6M price change	17.56%
6M total return	17.56%
All-time high	EUR 84.85
All-time high date	2022-04-14
All-time low	EUR 41.83
All-time low date	2020-03-24
Average true range (ATR)	EUR 1.18
Average volume	0
Change from 52-week high	-3.75%
Change from 52-week low	43.6%
Change from all-time high	-9.25%
Change from all-time low	84.1%
Change from open	0%
Day's gap	0.65%
High price	EUR 77.50
Low price	EUR 76.50
Monthly RSI	60.01
Open price	EUR 77.00
Position in 52-week range	50%
Previous close	EUR 76.50
Price vs 150-day SMA	7.26%
Price vs 20-day SMA	1.52%
Price vs 200-day SMA	9.43%
Price vs 50-day SMA	1.06%
Relative volume	13.53
RSI	55
Sharpe ratio	1.37
Sharpe ratio (3Y)	0.36
Sharpe ratio (5Y)	0.07
Sortino ratio	2.56
Sortino ratio (3Y)	0.79
Sortino ratio (5Y)	0.34
Weekly RSI	58.82
YTD price change	18.53%
YTD total return	18.53%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	91.7M
Shares change (QoQ)	-1.44%
Shares change (YoY)	-6.06%
Shares held by insiders	1.19%
Shares held by institutions	97.27%
Short ratio	7.7 days

Deeper analysis on VIE/HSIC

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/HSIC report

Is a complete VIE/HSIC research report available?

No complete published report is available for vie/HSIC (VIE/HSIC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/HSIC (VIE/HSIC)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/HSIC

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All VIE/HSIC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/HSIC

Frequently asked questions